Skip to main content
Publications
Sauchelli S , Jimenez-Murcia S, Sanchez I, Riesco N, Custal N, Fernandez-Garcia JC, Garrido-Sanchez L, Tinahones FJ, Steiger H, Israel M, Banos RM, Botella C, de la Torre R, Fernandez-Real JM, Ortega FJ, Fruhbeck G, Granero R, Tarrega S, Crujeiras AB, Rodriguez A, Estivill X, Beckmann JS, Casanueva FF, Menchon JM, Fernandez-Aranda F. Orexin and sleep quality in anorexia nervosa: clinical relevance and influence on treatment outcome . Psychoneuroendocrinology. 2016 Mar;65:102-8. doi: 10.1016/j.psyneuen.2015.12.014
Nastoupil LJ, Sinha R, Byrtek M, Ziemiecki R , Zhou X , Taylor M, Friedberg JW, Link BK, Cerhan JR, Dawson K, Flowers CR. Outcomes following watchful waiting for stage II–IV follicular lymphoma patients in the modern era . Br J Haematol. 2016 Mar;172(5):724-34. doi: 10.1111/bjh.13895
Nabhan C, Byrtek M, Rai A, Dawson K, Zhou X , Link BK, Friedberg JW, Zelenetz AD, Maurer MJ, Cerhan JR, Flowers CR. Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma-related mortality in elderly follicular lymphoma in the United States . Br J Haematol. 2015 Jul;170(1):85-95. doi: 10.1111/bjh.13399
Samelson EJ, Miller PD, Christiansen C, Daizedeh NS, Grazette L, Anthony MS , Egbuna O, Wang A, Siddhanti SR, Cheung AM, Franchimont N, Kiel DP. RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk . J Bone Miner Res. 2014 Feb;29(2):450-7. doi: 10.1002/jbmr.2043
Harrison CN, Mesa RA, Kiladjian J-J, Al-Ali H-K, Gisslinger H, Knoops L, Squier M, Sirulnik A, Mendelson E, Zhou X , Copley-Merriman C , Hunter DS, Levy RS, Cervantes F, Passamonti F, Barbui T, Barosi G, Vannucchi AM. Health-related quality of life and symptoms in patients with myelofibrosis treated with ruxolitinib versus best available therapy . Br J Haematol. 2013 Jul;162(2):229-39. doi: 10.1111/bjh.12375